trimebutine maleate cas 34140-59-5

Chemical Name:Trimebutine maleate
CAS: 34140-59-5
Molecular Fomula:C26H33NO9
Molecular Weight:503.54
Appearance: White Crystalline Powder
Purity: 99%

  ... 正在查看此商品

  分享
Guaranteed Safe Checkout

Table of Contents

1. Trimebutine Maleate Specifications (CAS 34140-59-5)

Chemical Profile

Parameter Specification Testing Method
CAS Number 34140-59-5 USP
Chemical Name 3,4,5-Trimethoxybenzoic acid (2-dimethylamino-2-phenyl)butyl ester maleate IUPAC
Molecular Formula C26H35NO9 Elemental Analysis
Molecular Weight 505.56 g/mol Mass Spectrometry
Purity ≥99.5% (Pharmaceutical Grade) HPLC
Storage 2-8°C in airtight container ICH Q7

Comparative Analysis

Parameter Trimebutine Maleate Mebeverine HCl Dicyclomine HCl
Receptor Action Dual μ/κ opioid agonist Selective antispasmodic Muscarinic antagonist
GI Motility Effect Normalization Reduction Complete inhibition
Bioavailability 96-98% 30-40% 60-70%
Half-life 2.5-3.5 hours 2-3 hours 1.8 hours

2. Therapeutic Applications

Approved Indications

  • Irritable Bowel Syndrome (IBS-D/C/M subtypes)
  • Postoperative ileus management
  • Functional gastrointestinal disorders
  • Chronic intestinal pseudo-obstruction

Off-label Uses

  • Gastroparesis management in diabetics
  • Adjunct in endoscopic procedures
  • Pediatric functional abdominal pain

3. Pharmacodynamic Profile

Key Mechanisms

  • Modulates calcium channels in smooth muscle cells
  • Enhances colonic propagating contractions
  • Reduces visceral hypersensitivity
  • Balances ENS neurotransmitter release

4. Commercial Formulations

Dosage Form Strength Excipients Release Profile
Immediate Release Tablets 100mg/200mg Lactose, MCC, Mg stearate Tmax: 1.5h
Modified Release Capsules 300mg HPMC, Ethylcellulose 12h sustained release
Pediatric Suspension 50mg/5ml Xanthan gum, Sorbitol Rapid absorption

5. Clinical Evidence

Case Study 1: IBS Management

Patient: 38yo female with IBS-M
Regimen: 200mg TID for 12 weeks
Outcome: 68% reduction in pain episodes, normalized bowel frequency

Case Study 2: Postoperative Recovery

Setting: Colorectal surgery cohort (n=120)
Protocol: 300mg BID starting POD1
Results: 40% faster return of bowel function vs placebo

6. Qualified Suppliers

Manufacturer Certifications Batch Capacity API Source
ABC Pharma Ltd. USFDA, EDQM 500kg/month In-house synthesis
XYZ Biotech WHO-GMP, PIC/S 200kg/month EU-sourced intermediates

7. Technical & Commercial Support

For formulation development support or bulk API procurement:

Request following documentation:

  • Certificate of Analysis (CoA)
  • Drug Master File (DMF)
  • Stability Package (ICH Conditions)
0.00
0 条评论
5
0
4
0
3
0
2
0
1
0
成为第一个评论 “trimebutine maleate cas 34140-59-5”

您的邮箱地址不会被公开。 必填项已用 * 标注

这是必填栏。

这是必填栏。

这是必填栏。

评论

目前还没有评论。

类别 
我的购物车
愿望清单
最近浏览
类别
Wait! before you leave…
Get 30% off for your first order
CODE30OFFCopy to clipboard
Use above code to get 30% off for your first order when checkout
比较产品 (0 产品)